Agenda

Friday November 01, 2024

• 8:00 AM – 8:05 AM

  Welcome

  • Co-Chair
    • Erika HamiltonMD
• 8:05 AM – 8:20 AM

  Debate: Advances in Early TNBC with Immunotherapy – Should We Continue Immunotherapy Post Surgery? - YES

  • Presenter
    • Tiffany TrainaMD, FASCO
• 8:20 AM – 8:35 AM

  Debate: Advances in Early TNBC with Immunotherapy – Should We Continue Immunotherapy Post Surgery? - NO

  • Presenter
    • Melinda TelliMD, FASCO
• 8:35 AM – 8:45 AM

  Debate: Advances in Early TNBC with Immunotherapy – Should We Continue Immunotherapy Post Surgery? - DISCUSSION

  • Moderator
    • Erika HamiltonMD
  • Panelist
    • Melinda TelliMD, FASCO
    • Tiffany TrainaMD, FASCO
• 8:45 AM – 9:00 AM

  Debate: Antibody Drug Conjugates as the New Frontier: Should We Use Them Sequentially? - Yes, They Are Better than Chemo

  • Presenter
    • Kelly McCannMD, PhD
• 9:00 AM – 9:15 AM

  Debate: Antibody Drug Conjugates as the New Frontier: Should We Use Them Sequentially? - No, the Benefit Is Really Just for the First ADC

  • Presenter
    • Denise YardleyMD
• 9:15 AM – 9:25 AM

  Debate: Antibody Drug Conjugates as the New Frontier: Should We Use Them Sequentially? - DISCUSSION

  • Moderator
    • Erika HamiltonMD
  • Panelist
    • Denise YardleyMD
    • Kelly McCannMD, PhD
• 9:25 AM – 9:35 AM

  Break

• 9:35 AM – 10:35 AM

  Non-CME Innovation Theater - Sponsored by Pfizer Oncology

• 10:35 AM – 10:50 AM

  Debate: Novel Endocrine Agents: Do PROTAC, CERAN, SERM, SERCA Really Add Anything Different than SERDs? - YES

  • Presenter
    • Seth WanderMD, PhD